The long term aim of this proposal is to obtain a better understanding of physiological roles of individuals isozymes of human """"""""low Km"""""""" aldehyde dehydrogenase (EC 1.2.1.3); the short term aim is to obtain information about individual isozymes. The recently purified E3 isozyme (from liver) is involved in polyamine metabolism and conversion of putrescine to GABA- a metabolic pathway which may be affected by ethanol metabolism. The proposed experiments include completion of E3 isozyme cDNA cloning, expression and purification of E3 isozyme, characterization of the E3 isozyme via determination of its kinetic mechanism, its coenzyme binding properties and investigation of some inhibitors. Development of an antibody, which is specific for the E3 isozyme, to be used in tissue distribution studies by isoelectric focusing, crossed immunoelectrophoresis, and ELISA assay is also proposed. Tissues from normal and from alcoholic subjects will be used. Our Preliminary Data demonstrated that on isoelectric focusing gel many different aldehyde dehydrogenase isozymes superimpose. Purification and cloning of these new aldehyde dehydrogenases from human liver and from human brain constitutes another part of this proposal. The procedures employed will include: ion exchange chromatography on CM sephadex and DEAE Sephadex and affinity chromatography on 5'AMP Sepharose, Blue Sepharose and NAD Agarose. Characterization will include: MW, subunit MW, amino terminal sequence, extinction coefficient, Km and V determinations for substrates and coenzymes. The newly purified enzymes will be cloned and cDNA will be sequenced. The main purpose of characterization will be identification of physiological substrates and determination of primary structure of enzyme deduced from cDNA, in order to unequivocally establish the identity of new enzymes. Acetaldehyde may compete for aldehyde dehydrogenase with natural substrates and thereby inhibit the natural substrate metabolism. By employing specific inhibitors of individual isozymes, their metabolic importance can be tested in the future. The proposed studies will therefore provide a groundwork for studies of the interaction between natural substrates and acetaldehyde. They may also result in increased knowledge of Genetic Factors in Alcoholism.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Research Project (R01)
Project #
5R01AA000186-23
Application #
2042885
Study Section
Biochemistry, Physiology and Medicine Subcommittee (ALCB)
Project Start
1975-04-01
Project End
1999-03-31
Budget Start
1996-06-01
Budget End
1999-03-31
Support Year
23
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Rutgers University
Department
Psychology
Type
Other Domestic Higher Education
DUNS #
038633251
City
New Brunswick
State
NJ
Country
United States
Zip Code
08901
Kikonyogo, A; Abriola, D P; Dryjanski, M et al. (1999) Mechanism of inhibition of aldehyde dehydrogenase by citral, a retinoid antagonist. Eur J Biochem 262:704-12
Chern, M K; Pietruszko, R (1999) Evidence for mitochondrial localization of betaine aldehyde dehydrogenase in rat liver: purification, characterization, and comparison with human cytoplasmic E3 isozyme. Biochem Cell Biol 77:179-87
Ambroziak, W; Izaguirre, G; Abriola, D et al. (1999) Metabolism of retinaldehyde by human liver and kidney. Adv Exp Med Biol 463:205-11
Ambroziak, W; Izaguirre, G; Pietruszko, R (1999) Metabolism of retinaldehyde and other aldehydes in soluble extracts of human liver and kidney. J Biol Chem 274:33366-73
Shah, P; Pietruszko, R (1999) Reaction-chemistry-directed sequence alignment of aldehyde dehydrogenases. Adv Exp Med Biol 463:9-14
Izaguirre, G; Kikonyogo, A; Pietruszko, R (1998) Methylglyoxal as substrate and inhibitor of human aldehyde dehydrogenase: comparison of kinetic properties among the three isozymes. Comp Biochem Physiol B Biochem Mol Biol 119:747-54
Dryjanski, M; Kosley, L L; Pietruszko, R (1998) N-tosyl-L-phenylalanine chloromethyl ketone, a serine protease inhibitor, identifies glutamate 398 at the coenzyme-binding site of human aldehyde dehydrogenase. Evidence for a second ""naked anion"" at the active site. Biochemistry 37:14151-6
Kikonyogo, A; Pietruszko, R (1997) Cimetidine and other H2-receptor antagonists as inhibitors of human E3 aldehyde dehydrogenase. Mol Pharmacol 52:267-71
Izaguirre, G; Kikonyogo, A; Pietruszko, R (1997) Tissue distribution of human aldehyde dehydrogenase E3 (ALDH9): comparison of enzyme activity with E3 protein and mRNA distribution. Comp Biochem Physiol B Biochem Mol Biol 118:59-64
Pietruszko, R; Kikonyogo, A; Chern, M K et al. (1997) Human aldehyde dehydrogenase E3. Further characterization. Adv Exp Med Biol 414:243-52

Showing the most recent 10 out of 15 publications